Empagliflozin 25 MG clinical trials

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

This study looks at a new type of medicine called Empagliflozin for people with kidney failure on peritoneal dialysis. It aims to see if the medicine is safe and how it works to protect remaining kidney function over two weeks.